Development of cell-specific and organelle-specific delivery systems by surface modification of lipid-based pharmaceutical nanocarriers
The use of lipid-based pharmaceutical nanocarriers, such as lipid-core polymeric micelles and liposomes have improved the pharmacokinetic and pharmacodynamic properties of many pharmaceuticals, especially in chemotherapy. These delivery systems have not only helped in increasing the solubility of po...
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20002485 |
Similar Items
-
Lipid-Based Nanocarrier System for the Effective Delivery of Nutraceuticals
by: Parthasarathi Subramanian
Published: (2021-09-01) -
Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery
by: Sebastien Benizri, et al.
Published: (2018-01-01) -
Induction of Mycobacterium Tuberculosis Lipid-Specific T Cell Responses by Pulmonary Delivery of Mycolic Acid-Loaded Polymeric Micellar Nanocarriers
by: Shaobin Shang, et al.
Published: (2018-11-01) -
Surface modification of nanocarriers for intra-cellular and sub-cellular targeting and delivery
Published: () -
Degradation of Organelles or Specific Organelle Components via Selective Autophagy in Plant Cells
by: Simon Michaeli, et al.
Published: (2014-05-01)